Page last updated: 2024-10-23

bromhexine and Scleroderma, Systemic

bromhexine has been researched along with Scleroderma, Systemic in 2 studies

Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konopik, J2
Krs, V1

Other Studies

2 other studies available for bromhexine and Scleroderma, Systemic

ArticleYear
[Conservative treatment of chronic lymphedema and sclerotic skin processes].
    Zeitschrift fur arztliche Fortbildung, 1984, Volume: 78, Issue:8

    Topics: Bromhexine; Female; Glycosaminoglycans; Humans; Leg Ulcer; Lymphedema; Male; Scleroderma, Localized;

1984
[Treatment of scleroderma with depolymerizing agents].
    Casopis lekaru ceskych, 1982, Nov-05, Volume: 121, Issue:44

    Topics: Bromhexine; Female; Humans; Hyaluronoglucosaminidase; Male; Scleroderma, Localized; Scleroderma, Sys

1982